Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhijit Parolia

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|May 7, 2026
Rewiring Oncogenic Transcriptional Complexes with Domain-ALTeration Chimeras (DALTACs) in Prostate CancerJie Luo, Jianzhang Yang, Jean Ching-Yi Tien, et al.
Nature Communications|June 28, 2024
PIKfyve, expressed by CD11c-positive cells, controls tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Nature|May 14, 2025
STAT5 and STAT3 balance shapes dendritic cell function and tumour immunityJiajia Zhou, Kole Tison, Haibin Zhou, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancerTongchen He, Caleb Cheng, Yuanyuan Qiao, et al.
Science Translational Medicine|November 25, 2016
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomasJill Bayliss, Piali Mukherjee, Chao Lu, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
PIKfyve controls dendritic cell function and tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2024
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancerTongchen He, Caleb Cheng, Yuanyuan Qiao, et al.
Cell|July 5, 2024
Progestogen-driven B7-H4 contributes to onco-fetal immune toleranceJiali Yu, Yijian Yan, Shasha Li, et al.
Nature Genetics|October 3, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancerJie Luo, Zhixiang Chen, Yuanyuan Qiao, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesisAbhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|May 7, 2026
Rewiring Oncogenic Transcriptional Complexes with Domain-ALTeration Chimeras (DALTACs) in Prostate CancerJie Luo, Jianzhang Yang, Jean Ching-Yi Tien, et al.
Nature Communications|June 28, 2024
PIKfyve, expressed by CD11c-positive cells, controls tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Nature|May 14, 2025
STAT5 and STAT3 balance shapes dendritic cell function and tumour immunityJiajia Zhou, Kole Tison, Haibin Zhou, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancerTongchen He, Caleb Cheng, Yuanyuan Qiao, et al.
Science Translational Medicine|November 25, 2016
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomasJill Bayliss, Piali Mukherjee, Chao Lu, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
PIKfyve controls dendritic cell function and tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2024
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancerTongchen He, Caleb Cheng, Yuanyuan Qiao, et al.
Cell|July 5, 2024
Progestogen-driven B7-H4 contributes to onco-fetal immune toleranceJiali Yu, Yijian Yan, Shasha Li, et al.
Nature Genetics|October 3, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancerJie Luo, Zhixiang Chen, Yuanyuan Qiao, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesisAbhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma, et al.
Pageof 6